Additionally, Bufalin has been shown to inhibit tumor microenvironment-mediated angiogenesis by down-regulating the expression of pro-angiogenic genes, including VEGF, PDGFA, e-selectin, and p-selectin in HUVECs through the inhibition of the STAT3 pathway. This evidence concerns the gene VEGFA and neoplasm.